Hypoglycemia

Recognizing Hypoglycemia

Hypoglycemia is low blood glucose that can impair thinking, function, and safety, and in its severe form is life-threatening. Common causes include too much insulin or sulfonylurea relative to food intake, delayed or missed meals, increased or unplanned physical activity, alcohol consumption without food, and renal impairment (which slows insulin clearance). Early adrenergic symptoms come from the counter-regulatory (epinephrine) response and include shakiness, sweating, palpitations, tachycardia, anxiety, and hunger. As glucose falls further, neuroglycopenic symptoms appear because the brain is starved of fuel: difficulty concentrating, confusion, blurred vision, slurred speech, irritability, and dizziness, progressing — if untreated — to seizure, loss of consciousness, coma, or death. Warning symptoms can be blunted by beta-blockers, alcohol, sleep, and repeated hypoglycemic episodes.

ADA Hypoglycemia Levels

The American Diabetes Association (ADA) Standards of Care classify hypoglycemia into three levels based on glucose value and clinical severity:

Level 3 is defined by the need for outside help, not a specific number — a person found unconscious or seizing is Level 3 regardless of the meter reading.

Hypoglycemia Unawareness

Hypoglycemia unawareness is the loss of early adrenergic warning symptoms, so the first sign of a low may be neuroglycopenic (confusion, seizure) rather than shakiness or sweating. It develops after recurrent hypoglycemia, long-standing type 1 diabetes, very tight glycemic control, autonomic neuropathy, sleep, and use of beta-blockers or alcohol. Each hypoglycemic episode blunts the counter-regulatory response to the next one, creating a cycle of escalating risk sometimes called hypoglycemia-associated autonomic failure. Management includes real-time continuous glucose monitoring (CGM) with low-glucose and predictive alerts, individualized (temporarily relaxed) glycemic targets, structured hypoglycemia education, and strict avoidance of hypoglycemia for several weeks — which can partially restore symptom awareness.

Special Situations: Nocturnal and Exercise-Related Hypoglycemia

Nocturnal hypoglycemia is common because counter-regulatory responses are blunted during sleep, so lows can go unrecognized until morning grogginess, headache, or night sweats are reported. CGM alarms are especially valuable overnight. Post-exercise delayed-onset hypoglycemia can occur many hours after activity — sometimes overnight — as muscle and liver glycogen stores replenish and insulin sensitivity remains elevated; people should check glucose after vigorous or prolonged exercise, consider a bedtime snack, and, for those with access, review CGM trends before sleep. For safety, ADA and driving guidance generally recommend a blood glucose of at least 70 mg/dL, confirmed by self-monitoring, before driving or operating machinery.

Treating Non-Severe Hypoglycemia: The 15-15 Rule

For a conscious person able to swallow safely with glucose below 70 mg/dL:

Pure glucose is the preferred treatment because it raises blood glucose fastest and predictably; fat and protein slow carbohydrate absorption and should not be the primary treatment for an acute low. People using an automated insulin delivery (AID)/hybrid closed-loop system typically need only 5-10 grams, since the pump is already suspending or reducing insulin delivery. Overtreating hypoglycemia with excess carbohydrate causes rebound hyperglycemia and should be avoided.

Severe Hypoglycemia (Level 3) and Glucagon

When a person cannot safely swallow, is unconscious, or is seizing, glucagon — not oral carbohydrate — is required. Modern glucagon rescue options include:

• Nasal glucagon (e.g., Baqsimi) — a single-dose intranasal spray; no injection or reconstitution needed
• Prefilled autoinjector pen or prefilled syringe (e.g., Gvoke, Zegalogue) — ready-to-use subcutaneous injection, no mixing required
• Traditional glucagon emergency kit — powder that must be reconstituted with a diluent, then drawn up and injected IM or SC; still available but now less preferred because of the time and steps required during an emergency

ADA recommends that glucagon be prescribed for everyone who takes insulin or is otherwise at high risk for hypoglycemia (for example, sulfonylurea use), with prefilled and ready-to-use formulations preferred over powder-reconstitution kits. Family members, caregivers, school personnel, and other support people should know where glucagon is kept and be trained to administer it. After glucagon administration, position the person on their side (glucagon commonly causes vomiting) and monitor closely; call emergency services if there is no response within about 15 minutes, glucagon is unavailable, or the person has recurrent severe hypoglycemia.

Prevention

Preventing hypoglycemia relies on structured diabetes self-management education, consistent CGM use with alarms enabled, reviewing glucose patterns for recurring trends, and matching insulin/medication doses to food intake and physical activity, including planning ahead for post-exercise delayed-onset hypoglycemia. Additional strategies include avoiding alcohol on an empty stomach, carrying fast-acting carbohydrate at all times, and individualizing glycemic targets for people at higher hypoglycemia risk — older adults, those with hypoglycemia unawareness, renal impairment, or limited life expectancy. Every hypoglycemic event should trigger a review of medications known to cause hypoglycemia (insulin, sulfonylureas) and a plan adjustment, rather than simply advising the person to eat more.